CAS 14365-45-8
:2'-DÉSOXY-B-L-ADÉNOSINE
- 9-(2-deoxy-beta-L-threo-pentofuranosyl)-9H-purin-6-amine
(2S,3R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
CAS :Formule :C10H13N5O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :251.24199-(2-Deoxy-β-L-Ribofuranosyl)Adenine
CAS :9-(2-Deoxy-β-L-Ribofuranosyl)AdenineDegré de pureté :98%Masse moléculaire :251.24g/mol2'-Deoxy-beta-L-adenosine
CAS :Produit contrôléApplications A useful synthon for modified oligodeoxyribonucleotides.
References Fujimori, S., et al.: Nucleoside & Nucleotide, 11(2-4), 341 (1992)Formule :C10H13N5O3Couleur et forme :NeatMasse moléculaire :251.242’-Deoxy-β-L-adenosine (May contain up to 20% inorganics)
CAS :Produit contrôléFormule :C10H13N5O3Couleur et forme :NeatMasse moléculaire :251.242'-Deoxy-L-adenosine
CAS :2'-Deoxy-L-adenosine is an adenosine analogue that has been shown to inhibit the growth of tumor cells in mice. The mechanism of this inhibition is not well understood, but it is thought that 2'-deoxy-L-adenosine inhibits the adenosine A3 receptor and blocks the activation of toll-like receptors. This drug also has been shown to have anti-inflammatory properties, which may be due to its ability to inhibit prostaglandin synthesis. It has been used as a model system for studying cellular responses to DNA damage caused by ultraviolet radiation. 2'-Deoxy-L-adenosine also has been shown to have a cytotoxic effect on human HL60 cells, which is mediated by nuclear DNA fragmentation.
Formule :C10H13N5O3Degré de pureté :Min. 98 Area-%Couleur et forme :Off-White PowderMasse moléculaire :251.25 g/mol





